These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12528363)

  • 1. Genomic medicine and neuroblastoma.
    Oppenheimer O; Alaminos M; Gerald WL
    Expert Rev Mol Diagn; 2003 Jan; 3(1):39-54. PubMed ID: 12528363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
    Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
    Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
    Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly?
    Jarzembowski JA
    Surg Pathol Clin; 2020 Dec; 13(4):625-641. PubMed ID: 33183724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
    Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF
    Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neuroblastoma: from basic science to clinical debut of cellular oncogenes.
    Schwab M
    Naturwissenschaften; 1999 Feb; 86(2):71-8. PubMed ID: 10084150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
    Ahmed AA; Zhang L; Reddivalla N; Hetherington M
    Pediatr Hematol Oncol; 2017 Apr; 34(3):165-185. PubMed ID: 28662353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
    Aygun N
    Curr Pediatr Rev; 2018; 14(2):73-90. PubMed ID: 29380702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.
    Vercouillie N; Ren Z; Terras E; Lammens T
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synopsis of unbalanced chromosome aberrations in neuroblastoma by comparative genomic hybridization].
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Böcker W; Störkel S
    Pathologe; 1996 Sep; 17(5):368-73. PubMed ID: 8992479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma: a multiple biological disease.
    Tonini GP
    Eur J Cancer; 1993; 29A(6):802-4. PubMed ID: 8484968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
    McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
    Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
    Axelson H; Fredlund E; Ovenberger M; Landberg G; Påhlman S
    Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.